This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The overall goal of this application is to develop novel methods for producing transgenic animals that can also be applied in gene therapy. Traditional methods of genetic engineering and transgenesis insert genes at random locations within the large genome of higher organisms, resulting in loss of efficiency, unpredictable results and unintended genetic consequences. Most current methods of transgenesis rely on the repair mechanisms of the zygote nucleus for the insertion of a transgene (tg) and have relatively low efficiency. We are developing what we term """"""""Active Transgenesis"""""""" methods in which transposases, enzymes that insert DNA into the cell's chromosomes, are injected into the oocyte to increase the efficiency of transgene integration into the genome. We have recently described a method to do this in which the gene for the transposase is injected with the gene that will be inserted into the mouse genome. The oocyte then makes the transposase, and the transposase inserts the gene into the oocyte's chromosomes. In this project, we will test how useful this method is, and whether it can also be used to take out genes from mice, not only to add them. Finally, we will test whether this new method of active transgenesis can be used for gene therapy for the treatment of human disease. This project, therefore, has significance for both the generation of novel genetically engineered mice for the study of human disease, and for the treatment of human disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR024206-04
Application #
8360324
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Project Start
2011-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
4
Fiscal Year
2011
Total Cost
$223,156
Indirect Cost
Name
University of Hawaii
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Goh, William A; Zalud, Ivica (2016) Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta. J Matern Fetal Neonatal Med 29:1795-800
Riches, Zoe; Abanda, Ngu; Collier, Abby C (2015) BCRP protein levels do not differ regionally in adult human livers, but decline in the elderly. Chem Biol Interact 242:203-10
Collier, Abby C; Thévenon, Audrey D; Goh, William et al. (2015) Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term. Eur J Drug Metab Pharmacokinet 40:471-80
Rose, Aaron H; Hoffmann, FuKun W; Hara, Jared H et al. (2015) Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses. Hum Vaccin Immunother 11:2305-11
Sato, Brittany L; Ward, Monika A; Astern, Joshua M et al. (2015) Validation of murine and human placental explant cultures for use in sex steroid and phase II conjugation toxicology studies. Toxicol In Vitro 29:103-12
Li, Zicong; Zeng, Fang; Meng, Fanming et al. (2014) Generation of transgenic pigs by cytoplasmic injection of piggyBac transposase-based pmGENIE-3 plasmids. Biol Reprod 90:93
Bertino, Pietro; Urschitz, Johann; Hoffmann, Fukun W et al. (2014) Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8(+) T cell responses. Vaccine 32:1670-7
Dewitt, J; Ochoa, V; Urschitz, J et al. (2014) Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line. Oncogene 33:977-85
Comptour, Aurélie; Moretti, Charlotte; Serrentino, Maria-Elisabetta et al. (2014) SSTY proteins co-localize with the post-meiotic sex chromatin and interact with regulators of its expression. FEBS J 281:1571-84
Vernet, Nadège; Mahadevaiah, Shantha K; Yamauchi, Yasuhiro et al. (2014) Mouse Y-linked Zfy1 and Zfy2 are expressed during the male-specific interphase between meiosis I and meiosis II and promote the 2nd meiotic division. PLoS Genet 10:e1004444

Showing the most recent 10 out of 49 publications